Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients
OBJECTIVE To assess whether the concentrations of serum advanced glycation end products (AGE) in diabetic patients with obstructive coronary artery disease differ from those in type 2 diabetic patients without obstructive coronary artery disease. DESIGN Serum AGE concentrations were measured in type...
Gespeichert in:
Veröffentlicht in: | British heart journal 2001-01, Vol.85 (1), p.87-91 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE To assess whether the concentrations of serum advanced glycation end products (AGE) in diabetic patients with obstructive coronary artery disease differ from those in type 2 diabetic patients without obstructive coronary artery disease. DESIGN Serum AGE concentrations were measured in type 2 diabetic patients and in non-diabetic patients, both with and without obstructive coronary artery disease, and the relation between these values and coronary disease severity was evaluated. RESULTS Mean (SD) serum AGE concentrations were higher (p |
---|---|
ISSN: | 1355-6037 0007-0769 1468-201X |
DOI: | 10.1136/heart.85.1.87 |